Diabetes Meets Determination with a Dash of Sass: An Up-Close interview with Lauren Plunkett
In this article for the publication diaTribe – Making Sense of Diabetes, I interviewed Lauren Plunkett, RD, CDCES. Lauren has had type 1 diabetes since her diagnosis at 11 years old. In her new book, Type One Determination, Lauren’s offers details of her personal journey
Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes
For T1D Exchange, I had the opportunity to interview Sean Salmon, President of Medtronic Diabetes. This interview covers Medtronic’s recent partnership with T1D Exchange and other diabetes entities to better understand and address the disparities that people of color with diabetes face.
What is Carbohydrate?
For my client LifeScan Diabetes Institute, I wrote and recorded a three-minute video titled, What is Carbohydrate?
New Consensus Report from ADA and EASD on the Management of T1D in Adults, Summarized
In late 2021 a new consensus report, The Management of Type 1 Diabetes in Adults, was published jointly by American Diabetes Association (in Diabetes Care) and European Study for Diabetes (EASD) (in Diabetologia). The report was developed by 14 content experts. The focus, interestingly, is on people 18 years of age and older.
Expanded Roles in Diabetes Care
RDs who specialize in diabetes care have been expanding their roles and responsibilities for the last decade or so. In this article I delve into the recent changes to titles as well as organizations and the rationale for them.
Status Update: Connected Insulin Delivery Devices
Until recently the only ways to take insulin, other than using an insulin pump, was via traditional pens or vial and syringe. Due to engineering and technological innovation there’s a growing cadre of insulin delivery devices called connected insulin delivery devices. In this blog for T1D Exchange, I define “connected” devices and review the rationale for their need.
Status Update: Automated Insulin Delivery Devices
While there’s LOTS of talk about what are now referred to as Automated Insulin Delivery (AID) systems (rather than artificial pancreas systems), many people don’t fully understand how these devices will work and what they’ll actually accomplish. This blog written for the T1D Exchange, describes the evolution to AID systems, details the current and near-future devices in a related table and discusses the clinical and mental health benefits of AID systems.
Latest News on CGM and Dexcom Straight from the CEO, Kevin Sayer
Bigfoot Unity Cleared and Ready to Step Out: Interview with Jeffrey Brewer, CEO, Bigfoot Biomedical
I was given the golden opportunity to interview a diabetes care and innovation guru, Jeffrey Brewer, for the T1D Exchange.